Vaxcyte, Inc. PCVX Lessee Operating Lease Liability Undiscounted Excess Amount
Lessee Operating Lease Liability Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s lessee operating lease liability undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s lessee operating lease liability undiscounted excess amount?
- Vaxcyte, Inc. (PCVX) reported lessee operating lease liability undiscounted excess amount of $44.82M in Q1 2026.
- How has Vaxcyte, Inc.'s lessee operating lease liability undiscounted excess amount changed year-over-year?
- Vaxcyte, Inc.'s lessee operating lease liability undiscounted excess amount increased by 22.2% year-over-year, from $36.69M to $44.82M.